The Beauty Health Company Reports Record Third Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
The Beauty Health Company (SKIN) PT Raised to $32 at DA Davidson
November 10, 2021 8:51 AM ESTDA Davidson analyst Linda Bolton Weiser raised the price target on The Beauty Health Company (NASDAQ: SKIN) to $32.00 (from $26.00) while maintaining a Buy rating.
The analyst commented, "SKIN reported a 3Q21 upside surprise, with sales beating consensus by 17% and EBITDA of $5.8M... More
The Beauty Health Company (SKIN) Reports Q3 Revenue of $68.1M
November 9, 2021 4:25 PM ESTThe Beauty Health Company (NASDAQ: SKIN) reported Q3 EPS of ($1.63), versus ($0.06) reported last year. Revenue for the quarter came in at $68.1 million, versus $34.6 million reported last year.
GUIDANCE:
The Beauty Health Company sees FY2021 revenue of $245-255 billion.
For... More
